Abiopharma

News list

Koopmans Chris 🔴 sold 10.0K shares of Marvell Technology, Inc. (MRVL) at $180.50 ($1.8M) Transaction Date: Aug 03, 2026 | Filing ID: 051905

Full text

News bot Aug. 3, 2026, 8:33 p.m.
🔍 Koopmans Chris (Executive)

Company: Marvell Technology, Inc. (MRVL)

Report Date: 2026-08-03
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 10,000
Detailed Transactions and Holdings:
- Sold 10,000 shares of Common Stock at $180.5 per share (Direct)
  Date: 2026-08-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 227,941.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
Footnotes:
- F1: Sales were made pursuant to a 10b5-1 Plan adopted by the Reporting Person on January 5, 2026.
- F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.63 to $185.07, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F3: Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.